靶向生物能量学阻止类风湿关节炎中CD4 T细胞介导的滑膜成纤维细胞活化
该研究探讨了类风湿关节炎(RA)炎性滑膜中成纤维样滑膜细胞(FLS)与T淋巴细胞的相互作用,并靶向FLS的细胞代谢通路。结果显示CD4 T细胞与FLS相互激活,CD4 T细胞条件培养基促进FLS侵袭和糖酵解、下调氧化磷酸化,而糖酵解抑制剂2-DG和AMP类似物AICAR可逆转这些效应,提示糖酵解调控可能对RA治疗具有临床意义。
要点
- CD4 T细胞与RA FLS相互激活,促进增殖、黏附分子表达及炎性因子分泌。
- CD4 T细胞条件培养基增强FLS侵袭性并上调糖酵解、下调氧化磷酸化。
- 糖酵解抑制剂2-DG和AMP类似物AICAR可逆转CD4 T细胞对FLS的激活效应。
核心结论
- CD4 T细胞诱导FLS侵袭性表型,FLS上调糖酵解以满足增加的代谢需求,2-DG和AICAR可阻止该激活,提示糖酵解调控可能对RA治疗有临床意义。
研究设计与样本
- 将RA FLS与CD4 T细胞或T细胞条件培养基(CD4CM)共培养,用流式细胞术检测增殖、黏附分子和胞内细胞因子,用transwell matrigel侵袭小室和ELISA检测侵袭性和分泌细胞因子,用Seahorse细胞外通量分析检测代谢谱,用实时定量RT-PCR定量基因表达。
主要发现
- CD4 T细胞与FLS相互激活,导致两者增殖增加及细胞间黏附分子1和血管细胞黏附分子1表达增加。
- CD4 T细胞与FLS相互作用增加TNF-α+、IFN-γ+和IL-17A+ CD4 T细胞频率,并增强TNF-α、IFN-γ、IL-17A、IL-6、IL-8和VEGF分泌。
- CD4CM促进FLS侵袭性并增强糖酵解、下调氧化磷酸化,同时增加葡萄糖转运体GLUT1和GLUT3、关键糖酵解酶GSK3A、HK2、LDHA和PFKFB3、血管生成因子VEGF及MMP-3和MMP-9。
- 糖酵解抑制剂2-DG和AMP类似物5-氨基咪唑-4-甲酰胺核糖核苷酸(AICAR)可逆转上述效应。
临床怎么用
- 糖酵解抑制剂2-DG和AMP类似物AICAR在体外可阻止CD4 T细胞介导的FLS活化,提示糖酵解调控可能成为RA治疗的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We investigated the reciprocal relationship linking fibroblast-like synoviocytes (FLS) and T lymphocytes in the inflamed RA synovium and subsequently targeted cellular metabolic pathways in FLS to identify key molecular players in joint inflammation. METHODS: RA FLS were cultured with CD4 T cells or T cell conditioned medium (CD4CM); proliferation, expression of adhesion molecules and intracellular cytokines were examined by flow cytometry. FLS invasiveness and secreted cytokines were measured by transwell matrigel invasion chambers and ELISA, while metabolic profiles were determined by extracellular Seahorse flux analysis. Gene expression was quantified by real-time quantitative RT-PCR. RESULTS: Our results showed mutual activation between CD4 T cells and FLS, which resulted in increased proliferation and expression of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 by both CD4 T cells and FLS. Furthermore, interaction between CD4 T cells and FLS resulted in an increased frequency of TNF-α+, IFN-γ+ and IL-17A+ CD4 T cells and augmented TNF-α, IFN-γ, IL-17A, IL-6, IL-8 and VEGF secretion. Moreover, CD4CM promoted invasiveness and boosted glycolysis in FLS while downregulating oxidative phosphorylation, effects paralleled by increased glucose transporters GLUT1 and GLUT3; key glycolytic enzymes GSK3A, HK2, LDHA and PFKFB3; angiogenic factor VEGF and MMP-3 and MMP-9. Importantly, these effects were reversed by the glycolytic inhibitor 2-DG and AMP analogue 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). CONCLUSION: This study demonstrates that CD4 T cells elicit an aggressive phenotype in FLS, which subsequently upregulate glycolysis to meet the increased metabolic demand. Accordingly, 2-DG and AICAR prevent this activation, suggesting that glycolytic manipulation could have clinical implications for RA treatment.
引用
- Petrasca A, Phelan JJ, Ansboro S, et al. Targeting bioenergetics prevents CD4 T cell-mediated activation of synovial fibroblasts in rheumatoid arthritis. Rheumatology (Oxford). 2020. PMID: 32047926. doi:10.1093/rheumatology/kez682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。